Following the U.S. Food and Drug Administration’s recent approval of Parsabiv™ (etelcalcetide), an IV formulation equivalent to the oral calcimimetic Sensipar® (cinacalcet), dialysis providers like … [Read more...]
Intravenous Form of Sensipar® Has Been Approved by the FDA
Parsabiv™ (etelcalcetide), an IV formulation similar to the oral calcimimetic Sensipar® (cinicalset), was recently approved by the U.S. Food and Drug Administration to treat secondary … [Read more...]
Nephrology News Roundup
Here’s a roundup of nephrology news over the past few weeks. Click on the headlines to browse the articles. Or, if you’ve discovered other newsworthy items that may be of interest to our team or your … [Read more...]
